LD-2 disclosure · 2nd Quarter - Report
WELLNESS PHARMACY
Client
- Description
- Compounding pharmacy.
- Location
- Alabama · United States of America
Registrant
- Description
- Government relations consultant.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018.
LobbyistsJAMES W ROCK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Health Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Patient Access to Compounded Medications Act of 2017.
LobbyistsJAMES W ROCK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
LobbyistsJAMES W ROCK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)